Beam Therapeutics Inc.
← Back to BEAM Overview

Beam Therapeutics Inc. (BEAM)

Solvency & Capital Structure

Total Debt

$250.8M

Net Debt

-$960.8M

Beam Therapeutics Inc. currently has $250.8M in total debt. Net debt is -$960.8M after cash offsets. This 'Net Cash' position indicates exceptional financial strength.

Financial Fundamentals

BEAMQuarterly Data • 5Y View

DateTotal Debt ($B)Cash & Inv. ($B)Net Debt ($B)Total AssetsDebt/Assets
2026-03-310.251.21-0.96Net Cash1.4816.9%
2025-12-310.291.25-0.95Net Cash1.4819.8%
2025-09-300.151.07-0.92Net Cash1.3111.5%
2025-06-300.151.15-1.00Net Cash1.3911.1%
2025-03-310.161.22-1.06Net Cash1.4710.8%
2024-12-310.160.85-0.69Net Cash1.1014.6%
2024-09-300.160.93-0.76Net Cash1.1713.8%
2024-06-300.171.01-0.84Net Cash1.2613.1%
2024-03-310.171.09-0.93Net Cash1.3612.4%
2023-12-310.171.19-1.02Net Cash1.4611.8%
2023-09-300.171.02-0.84Net Cash1.2913.4%
2023-06-300.181.07-0.90Net Cash1.3513.0%
2023-03-310.181.06-0.88Net Cash1.3313.2%
2022-12-310.181.08-0.90Net Cash1.3413.3%
2022-09-300.171.09-0.92Net Cash1.3513.0%
2022-06-300.181.17-0.99Net Cash1.4212.5%
2022-03-310.151.22-1.07Net Cash1.4510.3%
2021-12-310.150.97-0.82Net Cash1.4710.0%
2021-09-300.150.93-0.79Net Cash1.1612.6%
2021-06-300.140.62-0.47Net Cash0.8916.0%
2021-03-310.140.50-0.37Net Cash0.6919.7%
2020-12-310.110.30-0.19Net Cash0.4523.8%
2020-09-300.030.20-0.17Net Cash0.2812.3%
2020-06-300.040.23-0.19Net Cash0.3012.1%
2020-03-310.040.25-0.22Net Cash0.3211.1%
2019-12-310.030.09-0.06Net Cash0.1620.0%
2019-09-300.020.11-0.09Net Cash0.1713.7%
2019-06-300.020.13-0.10Net Cash0.1812.8%
2019-03-310.000.15-0.15Net Cash0.00
2018-12-310.000.15-0.15Net Cash0.170.0%
2018-03-310.000.00-0.00Net Cash0.00